Healthy Living/WellnessRoche Drug Ocrelizumab Proves Effective Against Multiple Sclerosis In Three Late-Stage Studies Results of clinical trials show promise in reducing the progression of the disease, researchers say. New drug could be on the market by 2017.by Jim Algar
Healthy Living/WellnessRoche's MS Drug Ocrelizumab Shows Promising Results After Late Stage Trialsby Julienne Roman
Healthy Living/WellnessExperimental Drug Ocrelizumab Proves Successful Against Hard-To-Treat Type Of Multiple Sclerosisby Ted Ranosa
Healthy Living/WellnessFDA Issues Approval For Bayer Autoinjector For Multiple Sclerosis Therapyby Dianne Depra
Healthy Living/WellnessBreastfeeding Mothers With MS May Have Lowered Risk Of Relapseby Rina Marie Doctor
Healthy Living/WellnessStudy Shows MS Patients Are Living Longer Lives But Still 7.5 Years Shorter Than Othersby Anu Passary
Healthy Living/WellnessCreams For Eczema And Athlete's Foot Can Reverse Multiple Sclerosisby Rhodi Lee
Healthy Living/WellnessDrinking Coffee Regularly May Reduce Risk Of Multiple Sclerosisby Dianne Depra
Healthy Living/WellnessStem Cell Therapy Shows Promise in Small Multiple Sclerosis Studyby Dianne Depra
Healthy Living/WellnessFDA Approves Multiple Sclerosis Drug Lemtrada by Genzyme, Comes with Boxed Warningby Anu Passary